Serum calcium and risk of migraine: A Mendelian randomization study

Human Molecular Genetics

Volumn 26, Issue 4, 2017, Pages 820-828

  Yin, Peter ^a   Anttila, Verneri ^b,c   Siewert, Katherine M ^d   Palotie, Aarno ^b,c,e   Smith, George Davey ^f   Voight, Benjamin F ^d  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e UNIVERSITY OF HELSINKI   (Finland)

^f UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM;

ADULT; ARTICLE; CALCIUM BLOOD LEVEL; CAUSALITY; CONTROLLED STUDY; ELECTRONIC HEALTH RECORD; FEMALE; GENETIC CORRELATION; HERITABILITY; HUMAN; HYPERCALCEMIA; HYPERLIPIDEMIA; HYPERTENSION; HYPOTHYROIDISM; ICD-9; MAJOR CLINICAL STUDY; MALE; MENDELIAN RANDOMIZATION ANALYSIS; MIDDLE AGED; MIGRAINE; PRIORITY JOURNAL; RISK FACTOR; SENSITIVITY ANALYSIS; AGED; BLOOD; CLINICAL TRIAL; GENETICS; MULTICENTER STUDY; QUANTITATIVE TRAIT;

ADULT; AGED; CALCIUM; FEMALE; HUMANS; HYPERCALCEMIA; MALE; MENDELIAN RANDOMIZATION ANALYSIS; MIDDLE AGED; MIGRAINE DISORDERS; QUANTITATIVE TRAIT, HERITABLE;

EID: 85018457923     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddw416     Document Type: Article

References (41)

1. Global Burden of Disease Study 2013 Collaborators. (2015) Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet, 386, 743-800.
2. Stovner, L.J., Zwart, J.A., Hagen, K., Terwindt, G.M. and Pascual, J. (2006) Epidemiology of headache in Europe. Eur. J. Neurol., 13, 333-345.
3. Gustavsson, A., Svensson, M., Jacobi, F., Allgulander, C., Alonso, J., Beghi, E., Dodel, R., Ekman, M., Faravelli, C., Fratiglioni, L., et al. (2011) Cost of disorders of the brain in Europe 2010. Eur. Neuropsychopharmacol., 21, 718-779.
4. Headache Classification Subcommittee of the International Headache Society. (2004) The International Classification of Headache Disorders: 2nd edition. Cephalalgia, 24 Suppl 1, 9-160.
5. Anttila, V., Winsvold, B.S., Gormley, P., Kurth, T., Bettella, F., McMahon, G., Kallela, M., Malik, R., de Vries, B., Terwindt, G., et al. (2013) Genome-wide meta-analysis identifies new susceptibility loci formigraine. Nat. Genet., 45, 912-917.
6. Kleeman, C.R., Massry, S.G. and Coburn, J.W. (1971) The clinical physiology of calcium homeostasis, parathyroid hormone, and calcitonin. II. Calif. Med., 114, 19-30.
7. Geelhoed, G.W. (1982) Parathyroid adenolipoma: clinical and morphologic features. Surgery, 92, 806-810.
8. Basso, U., Maruzzo, M., Roma, A., Camozzi, V., Luisetto, G. and Lumachi, F. (2011) Malignant hypercalcemia. Curr. Med. Chem., 18, 3462-3467.
9. Ozen, S., Celik, A., Alper, H., Simsek, D.G. and Darcan, S. (2010) Primary hyperparathyroidism in a young adult presenting with severe hypertension. J. Pediatr. Endocrinol. Metab., 23, 193-196.
10. Blair, D.R., Lyttle, C.S., Mortensen, J.M., Bearden, C.F., Jensen, A.B., Khiabanian, H., Melamed, R., Rabadan, R., Bernstam, E.V., Brunak, S., et al. (2013) A nondegenerate code of deleterious variants in Mendelian loci contributes to complex disease risk. Cell, 155, 70-80.
11. Davey Smith, G. and Ebrahim, S. (2003) 'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease? Int. J. Epidemiol., 32, 1-22.
12. Davey Smith, G. and Ebrahim, S. (2004) Mendelian randomization: prospects, potentials, and limitations. Int. J. Epidemiol., 33, 30-42.
13. Sheehan, N.A., Didelez, V., Burton, P.R. and Tobin, M.D. (2008) Mendelian randomisation and causal inference in observational epidemiology. PLoS Med., 5, e177.
14. Hingorani, A. and Humphries, S. (2005) Nature's randomised trials. Lancet, 366, 1906-1908.
15. Davey Smith, G. and Ebrahim, S. (2005) What can mendelian randomisation tell us about modifiable behavioural and environmental exposures? BMJ, 330, 1076-1079.
16. Cohen, J.C., Boerwinkle, E., Mosley, T.H., Jr. and Hobbs, H.H. (2006) Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. N. Engl. J. Med., 354, 1264-1272.
17. Voight, B.F., Peloso, G.M., Orho-Melander, M., Frikke-Schmidt, R., Barbalic, M., Jensen, M.K., Hindy, G., Hólm, H., Ding, E.L., Johnson, T., et al. (2012) Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study. Lancet, 380, 572-580.
18. Bulik-Sullivan, B., Finucane, H.K., Anttila, V., Gusev, A., Day, F.R. and Loh, P.R. ReproGen Consortium; Psychiatric Genomics Consortium. (2015) Genetic Consortium for Anorexia Nervosa of the Wellcome Trust Case Control Consortium 3, Duncan L, et al. An Atlas of Genetic Correlations across Human Diseases and Traits. Nat. Genet., 47, 1236-1241.
19. O'Seaghdha, C.M., Wu, H., Yang, Q., Kapur, K., Guessous, I., Zuber, A.M., Köttgen, A., Stoudmann, C., Teumer, A., Kutalik, Z., et al. (2013) Meta-analysis of genome-wide association studies identifies six new Loci for serum calcium concentrations. PLoS Genet., 9, e1003796.
20. The International Hapmap Consortium. (2010) Integrating common and rare genetic variation in diverse human populations. Nature, 467, 52-58.
21. Yin, P. and Voight, B.F. (2015) MeRP: a high-throughput pipeline for Mendelian randomization analysis. Bioinformatics, 31, 957-959.
22. Welter, D., MacArthur, J., Morales, J., Burdett, T., Hall, P., Junkins, H., Klemm, A., Flicek, P., Manolio, T., Hindorff, L. and Parkinson, H. (2014) The NHGRI GWAS Catalog, a curated resource of SNP-trait associations. Nucleic. Acids. Res., 42, D1001-D1006.
23. Evans, D.M. and Davey Smith, G. (2015) Mendelian Randomization: New Applications in the Coming Age of Hypothesis-Free Causality. Annu. Rev. Genomics. Hum. Genet., 16, 327-350.
24. Dastani, Z., Hivert, M.F., Timpson, N., Perry, J.R., Yuan, X., Scott, R.A., Henneman, P., Heid, I.M., Kizer, J.R., Lyytikäinen, L.P., et al. (2012) Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: amulti-ethnic meta-analysis of 45,891 individuals. PLoS Genet., 8, e1002607.
25. Bowden, J., Davey Smith, G. and Burgess, S. (2015) Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int. J. Epidemiol., 44, 512-525.
26. Burgess, S., Dudbridge, F. and Thompson, S.G. (2016) Combining information on multiple instrumental variables in Mendelian randomization: comparison of allele score and summarized data methods. Stat. Med., 35, 1880-1906.
27. Breslau, N. and Rasmussen, B.K. (2001) The impact of migraine: Epidemiology, risk factors, and co-morbidities. Neurology, 56, S4-12.
28. Scher, A.I., Terwindt, G.M., Picavet, H.S., Verschuren, W.M., Ferrari, M.D. and Launer, L.J. (2005) Cardiovascular risk factors and migraine: the GEM population-based study. Neurology, 64, 614-620.
29. Winsvold, B.S., Sandven, I., Hagen, K., Linde, M., Midthjell, K. and Zwart, J.A. (2013) Migraine, headache and development of metabolic syndrome: an 11-year follow-up in the Nord-Trøndelag Health Study (HUNT). Pain, 154, 1305-1311.
30. Lisotto, C., Mainardi, F., Maggioni, F. and Zanchin, G. (2013) The comorbidity between migraine and hypothyroidism. J. Headache Pain, 14, P138.
31. Meyer, J.S. and Hardenberg, J. (1983) Clinical effectiveness of calcium entry blockers in prophylactic treatment of migraine and cluster headaches. Headache, 23, 266-277.
32. Peroutka, S.J. (1983) The pharmacology of calcium channel antagonists: a novel class of anti-migraine agents? Headache, 23, 278-283.
33. Jackson, J.L., Cogbill, E., Santana-Davila, R., Eldredge, C., Collier, W., Gradall, A., Sehgal, N. and Kuester, J. (2015) A Comparative Effectiveness Meta-Analysis of Drugs for the Prophylaxis of Migraine Headache. PLoS One, 10, e0130733.
34. Zaheer, S., de Boer, I., Allison, M., Brown, J.M., Psaty, B.M., Robinson-Cohen, C., Ix, J.H., Kestenbaum, B., Siscovick, D. and Vaidya, A. (2016) Parathyroid Hormone and the Use of Diuretics and Calcium-Channel Blockers: The Multi-Ethnic Study of Atherosclerosis. J. Bone. Miner. Res., 31, 1137-1145.
35. Hebert, S.C., Brown, E.M. and Harris, H.W. (1997) Role of the Ca(2+)-sensing receptor in divalent mineral ion homeostasis. J. Exp. Biol., 200, 295-302.
36. Khan, A., Bilezikian, J., Bone, H., Gurevich, A., Lakatos, P., Misiorowski, W., Rozhinskaya, L., Trotman, M.L. and Tóth, M. (2015) Cinacalcet normalizes serum calcium in a doubleblind randomized, placebo-controlled study in patients with primary hyperparathyroidism with contraindications to surgery. Eur. J. Endocrinol., 172, 527-535.
37. EVOLVE Trial Investigators, Chertow, G.M., Block, G.A., Correa-Rotter, R., Drüeke, T.B., Floege, J., Goodman, W.G., Herzog, C.A., Kubo, Y., London, G.M., et al. (2012) Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis. N. Engl. J. Med., 367, 2482-2494.
38. Bulik-Sullivan, B.K., Loh, P.R., Finucane, H.K., Ripke, S., Yang, J., Schizophrenia Working Group of the Psychiatric Genomics Consortium, Patterson, N., Daly, M.J., Price, A.L. and Neale, B.M. (2015) LD Score regression distinguishes confounding from polygenicity in genome-wide association studies. Nat. Genet., 47, 291-295.
39. Lindner, G., Felber, R., Schwarz, C., Marti, G., Leichtle, A.B., Fiedler, G.M., Zimmermann, H., Arampatzis, S. and Exadaktylos, A.K. (2013) Hypercalcemia in the ED: prevalence, etiology, and outcome. Am. J. Emerg. Med., 31, 657-660.
40. Bowden, J., Davey Smith, G., Haycock, P.C. and Burgess, S. (2015) Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator. Genet. Epidemiol., 40, 304-314.
41. 2 statistic. Int. J. Epidemiol., in press, doi: 10.1093/ije/dyw220.